Skip to main content
Clinical Trials/NCT04545346
NCT04545346CompletedNot Applicable

The Potential of a Low Glutamate Diet in Refractory Pediatric Epilepsy Patients

American University1 site in 1 country45 target enrollmentStarted: October 15, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
45
Locations
1
Primary Endpoint
Change in seizure frequency

Study Overview

Brief Summary

The study is investigating if following the low glutamate diet for 1 month, as compared to care as usual, can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life in children with epilepsy.

Detailed Description

Epilepsy is estimated to effect 470,000 children within the U.S. About a third of epilepsy patients are refractory. For these patients, dietary therapy is an alternative option. However, current dietary therapies present issues with compliance, palatability, adverse events, and providing necessary nutrients for brain growth and development during childhood. A dietary option that can improve tolerability, increase compliance, and reduce or eliminate adverse effects, while also optimizing nutrient intake, is critical for the advancement of dietary therapy options in epilepsy.

Glutamate is found in the diet as a flavor enhancer; and is also an important neurotransmitter in the body which mediates seizure activity. Dietary sources of free glutamate are common and include numerous food additives (including many hidden sources) and some items which naturally contain higher amounts of glutamate. The low glutamate diet reduces the consumption of free glutamate, while optimizing dietary micronutrient and antioxidant intake, which can protect against the negative effects caused by high glutamate concentrations in the brain. Additionally, the low glutamate diet is balanced, nutritious and palatable, with no side effects.

The study is investigating if following the low glutamate diet for 1 month can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life, in children with epilepsy. Participation in the study will be done virtually and over a 2- or 3- month study period, depending on group randomization. All participants will have the opportunity to undergo dietary training and follow the diet.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
2 Years to 21 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •4 or more seizures per month
  • •Willing to keep all medications constant during the study.
  • •All medications have remained constant for 30 days prior to study enrollment
  • •Any previously attempted dietary therapies stopped before study enrollment

Exclusion Criteria

  • •Known or suspected inborn errors of metabolism
  • •Non-English speaking households

Arms & Interventions

Wait-listed control

No Intervention

Participants continue care as usual. All all medications must be kept constant during the study period, unless medically necessary.

Low Glutamate diet

Experimental

Participants are put on the low glutamate diet for one month. The low glutamate diet reduces the consumption of free glutamate, while optimizing dietary micronutrient and antioxidant intake.

Intervention: Low Glutamate diet (Other)

Outcomes

Primary Outcomes

Change in seizure frequency

Time Frame: At 1 month post treatment

All families will keep a seizure diary recording the number of daily seizures. This will be used to accurately determine these variables for the last week, which will be recorded on seizure assessment forms.

Change in seizure severity

Time Frame: At 1 month post treatment

. During the last week of each study period, families will be asked to complete a seizure assessment form. This will include a subjective rating scale for seizure severity with a minimum score of 0 (not severe) and a maximum score of 10 (very severe).

Change in seizure duration

Time Frame: At 1 month post treatment

All families will keep a seizure diary recording the duration of seizures. This will be used to accurately determine these variables for the last week, which will be recorded on seizure assessment forms.

Secondary Outcomes

  • The effect of a 1-month low-glutamate diet on quality of life in children with epilepsy.(At 1 month post treatment)
  • The effect of a 1-month low-glutamate diet on cognitive functioning in children with epilepsy.(At 1 month post treatment)
  • Examine change in resting state brain waves after 1-month on the low glutamate diet(At 1 month post treatment)

Investigators

Sponsor
American University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kathleen Holton

Associate Professor

American University

Study Sites (1)

Loading locations...

Similar Trials

The Potential of a Low Glutamate Diet as a... | Clinical Trial